Skip to content
The Nexus
DossierENTITY

squamous non-small-cell lung cancer

Coverage of squamous non-small-cell lung cancer in the Nexus archive.

Earliest in view: May 31 · 22:28 UTCMost recent: May 31 · 22:28 UTC
Co-mentioned in this coverage
Chinese drugtopic1Eli Lillyorganization1pancreatic cancer drugtopic1Chinese biotech industryorganization1lung cancertopic1
Recent coverage
  • HEALTHMay 31 · 22:28 UTCSEMAFOR
    Chinese drug reduces lung cancer death risk by 34% in trial

    A Chinese lung cancer drug reduced the risk of death by 34% in a late-stage trial, extending survival by four months when combined with chemotherapy for squamous non-small-cell lung cancer. The results highlight China's growing pharmaceutical innovation, alongside global advancements like Eli Lilly's obesity drug and a pancreatic cancer treatment.

squamous non-small-cell lung cancer · Dossier · The Nexus